Background & aims: Endoscopic improvement is an important treatment target for mild-to-moderate ulcerative colitis (UC). However, early endoscopic evaluation is not always feasible. We aimed to develop a clinical decision support tool to discriminate patients who have achieved endoscopic improvement from those with more severe inflammation following mesalamine induction therapy.


Endoscopic Improvement, Mesalamine, Mucosal Healing, Leukocyte L1 Antigen Complex, Drug Therapy, Ulcerative Colitis, Endoscopy, therapeutic use, Complications

Read More